Günay, Sibel, et al. “Risk Factors for the Development of Interstitial Lung Disease Following Severe COVID-19 Pneumonia and Outcomes of Systemic Corticosteroid Therapy: 3-Month Follow-Up: Interstitial Lung Disease Following Severe COVID-19 Pneumonia”. Sarcoidosis, Vasculitis and Diffuse Lung Diseases, vol. 40, no. 3, Sept. 2023, p. e2023029, https://doi.org/10.36141/svdld.v40i3.14418.